Cost Effectiveness of Caplacizumab in Acquired Thrombotic Thrombocytopenic Purpura

被引：1
|
作者：
Goshua, George
Sinha, Pranay
Hendrickson, Jeanne E.
Tormey, Christopher A.
Bendapudi, Pavan
Lee, Alfred Ian
机构：
来源：
BLOOD | 2020年 / 136卷
关键词：
D O I：
10.1182/blood-2020-138515
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
    Goshua, George
    Sinha, Pranay
    Hendrickson, Jeanne E.
    Tormey, Christopher
    Bendapudi, Pavan K.
    Lee, Alfred Ian
    BLOOD, 2021, 137 (07) : 969 - 976
  • [2] Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
    Abdelghany, Mazin T.
    Baggett, Meridale V.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (25): : 2497 - 2497
  • [3] Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
    Olson, Sven R.
    Samuelson-Bannow, Bethany T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (18):
  • [4] Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
    Peyvandi, Flora
    Scully, Marie
    Hovinga, Johanna A. Kremer
    Cataland, Spero
    Knoebl, Paul
    Wu, Haifeng
    Artoni, Andrea
    Westwood, John-Paul
    Taleghani, Magnus Mansouri
    Jilma, Bernd
    Callewaert, Filip
    Ulrichts, Hans
    Duby, Christian
    Tersago, Dominique
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (06): : 511 - 522
  • [5] CAPLACIZUMAB IN PEDIATRIC ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
    Kamath, Dipti
    Vissa, Madhva
    Matsunaga, Alison
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S140 - S140
  • [6] Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura Reply
    Scully, Marie
    Edou, Jessica Minkue Mi
    Callewaert, Filip
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (18):
  • [7] Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
    Scully, M.
    Cataland, S. R.
    Peyvandi, F.
    Coppo, P.
    Knobl, P.
    Hovinga, J. A. Kremer
    Metjian, A.
    de la Rubia, J.
    Pavenski, K.
    Callewaert, F.
    Biswas, D.
    De Winter, H.
    Zeldin, R. K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (04): : 335 - 346
  • [8] USE OF CAPLACIZUMAB IN THE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
    Dominguez Hernandez, L.
    De la Puerta Paula, R.
    Arnao Herraiz, M.
    Boso, V
    Palanques, T.
    Mejias Juan, E.
    Poveda, J. L.
    Solves Alcaina, P.
    Carpio Martinez, N.
    Sanz Santillana, C.
    Gomez Segui, I
    HAEMATOLOGICA, 2019, 104 : 354 - 355
  • [9] Caplacizumab in adult patients with acquired thrombotic thrombocytopenic purpura
    Hanlon, Ashley
    Metjian, Ara
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2020, 11
  • [10] Role of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura
    Reid, Justin H.
    Durant, Karin M.
    Chen, Sheh-Li
    Perissinotti, Anthony J.
    King, Richard
    Khoriaty, Rami
    Marini, Bernard L.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (07) : 1695 - 1702
12345